Auxier Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.6M Sell
36,367
-174
-0.5% -$57.2K 1.53% 20
2025
Q4
$12.8M Sell
36,541
-555
-1% -$188K 1.8% 13
2025
Q3
$12M Buy
37,096
+343
+0.9% +$107K 1.68% 15
2025
Q2
$14.3M Buy
36,753
+681
+2% +$274K 2.1% 9
2025
Q1
$15.7M Buy
36,072
+430
+1% +$173K 2.34% 7
2024
Q4
$13.1M Sell
35,642
-1,573
-4% -$658K 2.04% 9
2024
Q3
$19.4M Buy
37,215
+10
+0% +$5.34K 2.86% 5
2024
Q2
$20.2M Sell
37,205
-6,529
-15% -$3.45M 3.19% 4
2024
Q1
$22.7M Sell
43,734
-2,350
-5% -$1.17M 3.45% 3
2023
Q4
$21.7M Sell
46,084
-244
-0.5% -$113K 3.52% 3
2023
Q3
$20.2M Sell
46,328
-35
-0.1% -$15.9K 3.44% 3
2023
Q2
$20.6M Sell
46,363
-45
-0.1% -$20.8K 3.42% 3
2023
Q1
$21.3M Sell
46,408
-128
-0.3% -$60.9K 3.68% 3
2022
Q4
$23.9M Sell
46,536
-33
-0.1% -$16.8K 4.12% 3
2022
Q3
$21.2M Sell
46,569
-14
-0% -$6.7K 4.08% 3
2022
Q2
$22.5M Sell
46,583
-31
-0.1% -$15.3K 4.01% 3
2022
Q1
$22.9M Sell
46,614
-1,060
-2% -$485K 3.63% 3
2021
Q4
$22.1M Sell
47,674
-162
-0.3% -$68.2K 3.43% 3
2021
Q3
$17.8M Sell
47,836
-38
-0.1% -$14.4K 3.02% 4
2021
Q2
$18.3M Sell
47,874
-595
-1% -$227K 3.03% 4
2021
Q1
$17.4M Sell
48,469
-100
-0.2% -$32.2K 2.99% 5
2020
Q4
$15.6M Sell
48,569
-60
-0.1% -$18.4K 2.89% 7
2020
Q3
$13.1M Buy
48,629
+80
+0.2% +$21.5K 2.73% 8
2020
Q2
$12.8M Buy
48,549
+495
+1% +$132K 2.82% 8
2020
Q1
$10.9M Sell
48,054
-555
-1% -$151K 2.72% 9
2019
Q4
$14.7M Buy
48,609
+360
+0.7% +$99.1K 2.73% 7
2019
Q3
$11.6M Sell
48,249
-50
-0.1% -$13.7K 2.33% 8
2019
Q2
$13.6M Buy
48,299
+1,000
+2% +$273K 2.72% 7
2019
Q1
$13.6M Sell
47,299
-2,160
-4% -$625K 2.79% 5
2018
Q4
$13M Hold
49,459
2.89% 5
2018
Q3
$13.6M Sell
49,459
-287
-0.6% -$74.5K 2.56% 7
2018
Q2
$11.8M Sell
49,746
-413
-0.8% -$95.6K 2.37% 8
2018
Q1
$11M Buy
50,159
+465
+0.9% +$109K 2.21% 9
2017
Q4
$11.2M Sell
49,694
-625
-1% -$133K 2.15% 9
2017
Q3
$9.55M Sell
50,319
-1,800
-3% -$343K 1.94% 11
2017
Q2
$9.8M Sell
52,119
-75
-0.1% -$13.5K 2% 10
2017
Q1
$8.63M Sell
52,194
-2,500
-5% -$398K 1.81% 14
2016
Q4
$7.86M Sell
54,694
-150
-0.3% -$20.1K 1.71% 16
2016
Q3
$6.87M Sell
54,844
-1,200
-2% -$155K 1.54% 18
2016
Q2
$7.36M Hold
56,044
1.69% 15
2016
Q1
$7.79M Sell
56,044
-200
-0.4% -$26.7K 1.84% 14
2015
Q4
$7.84M Hold
56,244
1.78% 14
2015
Q3
$7.87M Sell
56,244
-50
-0.1% -$7.51K 1.84% 14
2015
Q2
$9.24M Sell
56,294
-5,700
-9% -$911K 1.92% 14
2015
Q1
$9.57M Sell
61,994
-1,142
-2% -$163K 1.93% 14
2014
Q4
$7.93M Sell
63,136
-260
-0.4% -$32.1K 1.58% 21
2014
Q3
$7.58M Hold
63,396
1.58% 20
2014
Q2
$6.82M Sell
63,396
-50
-0.1% -$5.15K 1.4% 24
2014
Q1
$6.32M Sell
63,446
-25
-0% -$2.26K 1.35% 26
2013
Q4
$5.86M Hold
63,471
1.23% 31
2013
Q3
$5.31M Hold
63,471
1.23% 30
2013
Q2
$5.19M Buy
+63,471
New +$4.75M 1.26% 28

Other funds holding ELV

Auxier Asset Management's ELV Position: Q1 2026 in Review

Auxier Asset Management reduced its Elevance Health (ELV) stake by 0.48% in Q1 2026, selling an estimated $57.2K and leaving 36,367 shares worth $10.6M. The position accounts for 1.53% of the portfolio, ranked #20.

Auxier Asset Management first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $23.9M in Q4 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Auxier Asset Management held 36,367 shares of Elevance Health worth $10.6M as of Q1 2026.
  • Auxier Asset Management sold 174 Elevance Health shares in Q1 2026, an estimated $57.2K.
  • Elevance Health made up 1.53% of Auxier Asset Management's portfolio in Q1 2026, its #20 holding.
  • Auxier Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
  • Auxier Asset Management's Elevance Health position peaked at $23.9M in Q4 2022.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Auxier Asset Management's 13F filing for Q1 2026, filed 14 May 2026.